TrialPloS one2016

Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study.

Mariann Gyöngyösi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.